When Should You Buy Synopsys, Inc. (NASDAQ:SNPS)?

Let's talk about the popular Synopsys, Inc. (NASDAQ:SNPS). The company's shares saw a decent share price growth in the teens level on the NASDAQGS over the last few months. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Synopsys’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Synopsys

Advertisement

What is Synopsys worth?

According to my valuation model, Synopsys seems to be fairly priced at around 6.93% above my intrinsic value, which means if you buy Synopsys today, you’d be paying a relatively fair price for it. And if you believe that the stock is really worth $243.25, there’s only an insignificant downside when the price falls to its real value. Although, there may be an opportunity to buy in the future. This is because Synopsys’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of Synopsys look like?

earnings-and-revenue-growth
NasdaqGS:SNPS Earnings and Revenue Growth April 6th 2021

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 34% over the next couple of years, the future seems bright for Synopsys. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? It seems like the market has already priced in SNPS’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping an eye on SNPS, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Since timing is quite important when it comes to individual stock picking, it's worth taking a look at what those latest analysts forecasts are. So feel free to check out our free graph representing analyst forecasts.

If you are no longer interested in Synopsys, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

If you decide to trade Synopsys, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About NasdaqGS:SNPS

Synopsys

Provides design IP solutions in the semiconductor and electronics industries.

Reasonable growth potential with mediocre balance sheet.

Advertisement

Weekly Picks

CE
Ceazar
GOAI logo
Ceazar on Eva Live ·

This small cap is building the AI workforce of the future

Fair Value:US$7.4352.0% undervalued
76 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
25 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative
WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3532.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
CA
Canderous
TAL logo
Canderous on PetroTal ·

Beyond 2026, Beyond a Double

Fair Value:CA$1.8168.5% undervalued
27 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

ES
ELRIDGE logo
Ester on Elridge Energy Holdings Berhad ·

Elridge’s Q1 Results Strengthen the Investment Case — Earnings Growth and Margin Expansion Could Support Further Share Price Upside Ahead

Fair Value:RM 1.3237.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BJ
Bjergby
DR logo
Bjergby on Medical Facilities ·

Medical Facilities (DR): Strong Balance Sheet, Cheap Assets, but Upside Hinges on Capital Allocation

Fair Value:CA$23.1524.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
BTSG logo
prajeesh on BrightSpring Health Services ·

BrightSpring Health Services will shine with future PE rising 69.72x

Fair Value:US$70.5917.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
114 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6118.3% undervalued
1194 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
25 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative